[Clinical practice guideline for postmenopausal osteoporosis with traditional Chinese medicine]

Author: Yan-Ming Xie1, Huan Liu1, Jun-Jie Jiang1, Xu Wei2, Hao Shen3, Ying-Jie Zhi1, Jing Sun4, Jin-Yu Li5, Xiao-Xia Bao5, Wei Shi6, Yi-Li Zhang7
Affiliation: <sup>1</sup> Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China. <sup>2</sup> Wangjing Hospital, Chinese Academy of Chinese Medical Sciences Beijing 100102, China. <sup>3</sup> Changxindian Community Health Service Center of Fengtai District Beijing 100072, China. <sup>4</sup> Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110032, China. <sup>5</sup> Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China. <sup>6</sup> Affiliated Hospital of Shandong University of Traditional Chinese Medicine Ji&#39;nan 250355, China. <sup>7</sup> Beijing University of Chinese Medicine Beijing 100029, China.
Conference/Journal: Zhongguo Zhong Yao Za Zhi
Date published: 2021 Nov 1
Other: Volume ID: 46 , Issue ID: 22 , Pages: 5992-5998 , Special Notes: doi: 10.19540/j.cnki.cjcmm.20210709.501. , Word Count: 271

The editorial group of the clinical practice guideline for postmenopausal osteoporosis(PMOP) with traditional Chinese medicine(TCM)(hereinafter referred to as &quot;guideline&quot;) is composed of experts specialized in TCM orthopedics, TCM gynecology, clinical epidemiology, etc. The guideline was formulated through registration, collection and selection of clinical issues/outcome indicators, evidence retrieval and screening, preparation of systematic reviews, evaluation of evidence quality, formation of recommendations, drafting, and peer review. The syndromes and treatment of PMOP are elaborated in detail. Specifically, Liuwei Dihuang Pills and Zuogui Pills are recommended for PMOP with Yin deficiency in the liver and kidney, Qing'e Pills for PMOP with kidney deficiency and blood stasis, Yougui Pills and Jingui Shenqi Pills for PMOP with Yang deficiency in the spleen and kidney, and Er'xian Decoction for PMOP with Yin and Yang deficiency in the kidney. In addition, Duhuo Jisheng Decoction can be used to relieve pain. The commonly used Chinese patent medicines include Xianling Gubao Capsules, Qianggu Capsules, Jintiange Capsules, Gushukang Capsules, Hugu Capsules, Jinwu Gutong Capsules, and Guyuling Capsules. Acupuncture and moxibustion are also effective approaches for PMOP. The rehabilitation and daily management were carried out by exercise therapies such as Baduanjin(eight-section brocade), Wuqinxi(five-animal exercises), and Taijiquan(Tai Chi), Chinese medicine diet, health education, and fall prevention. The promotion and application of this guideline will facilitate the implementation of TCM prevention and treatment of PMOP, ensure the quality of life of PMOP patients, provide effective and safe TCM treatment measures for PMOP, and reduce the risk of fracture complications.

Keywords: TCM clinical practice guideline; evidence-based guideline; postmenopausal osteoporosis.

PMID: 34951191 DOI: 10.19540/j.cnki.cjcmm.20210709.501